Readiness for AUC-Dosing of Vancomycin in Montana Hospitals

Authors

Staci Hemmer, University of Montana, Missoula

Document Type

Report

Publication Date

10-2021

Abstract

Vancomycin is an essential antibiotic for treating methicillin-resistant Staphylococcus Aureus (MRSA) infections. Vancomycin requires close monitoring because of its potential to damage the kidney.¹ Evidence now supports the use of a new parameter, area-under-the-curve (AUC), to monitor vancomycin dosing and recently has become the standard-of-care.^2,3,4 The preferred method for estimating AUC is with sophisticated, computer software using a Bayesian analysis. The expense of commercially available programs may be difficult to justify for hospitals with limited budgets, especially smaller hospitals that infrequently administer vancomycin to patients.

Rights

© 2021 Staci Hemmer

Recommended Citation

Hemmer, Staci, "Readiness for AUC-Dosing of Vancomycin in Montana Hospitals" (2021). University Grant Program Reports. 65.
https://scholarworks.umt.edu/ugp-reports/65